In 2010, Dick Cheney received an LVAD device ahead of a heart transplant, which resulted in him possibly living with no pulse ...

Pulse Biosciences ( PLSE 3.81%) reported its first revenues, marking initial commercial adoption of its nPulse platform and ...

The FDA has approved a Transcranial Magnetic Stimulation device to treat adolescents with severe depression, offering a ...

Operator: Hello, and thank you for standing by. My name is Mark, and I will be your conference operator today.

Data from the POWER PAD II Study presented at VIVA will support FDA 510 (k) submission in 2026 ...

With the new funds, the company’s valuation is nearly $1 billion, a Synchron spokesperson said. That makes it the second-most ...

Amplitude Vascular Systems (AVS) today announced findings from the first 95 patients treated in its POWER PAD II U.S. pivotal ...

The Supreme Court has overturned a decision that alleged pornographic material found on the phone of a Dublin -based garda ...

Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.

Network Status Screen: A stable internet connection is essential to ensure the best experience on PS Portal. You can now ...

Sony has unveiled that players can now officially stream games to their PlayStation Portal without needing PlayStation Remote ...

Pulse Biosciences Inc (($PLSE)) has held its Q3 earnings call. Read on for the main highlights of the call. Pulse Biosciences Inc. recently held ...